🇺🇸 Ciclosporine A in United States

12 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Leukaemia Recurrent — 2 reports (16.67%)
  2. Lung Infection — 2 reports (16.67%)
  3. Acidosis — 1 report (8.33%)
  4. Anaemia — 1 report (8.33%)
  5. Anaphylactic Reaction — 1 report (8.33%)
  6. Aphthous Ulcer — 1 report (8.33%)
  7. Arthritis — 1 report (8.33%)
  8. Blood Cholesterol Increased — 1 report (8.33%)
  9. Blood Creatine Increased — 1 report (8.33%)
  10. Blood Pressure Increased — 1 report (8.33%)

Source database →

Ciclosporine A in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Ciclosporine A approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ciclosporine A in United States?

Technische Universität Dresden is the originator. The local marketing authorisation holder may differ — check the official source linked above.